GM

George Montgomery

Director at Ashvattha Therapeutics

George Montgomery currently serves as a Managing Director at WestRiver Group (WRG), where he co-leads the Healthcare fund to guide investments in biotech/pharma, digital health, Medtech, and tech-enabled services. Before joining WRG, Montgomery was a partner at Gurnet Point Capital (GPC), a $2 billion dedicated global healthcare fund, and served on the boards of Gurnet Point portfolio companies: Crossover Health, Boston Pharmaceuticals, Before Brands, and Alladapt. Prior to GPC, he was a co-founder and Chief Financial Officer at Coherus Biosciences and has held leadership roles in banking with JPMorgan H&Q, Cowen, and CSFB. Additionally, Montgomery serves on non-profit boards including REDF, The Jackson Laboratory, and the Yale Cancer Center Advisory Board. He received his BA in Political Science from Yale College and an MBA in Finance from the Wharton School of Business at the University of Pennsylvania.


Timeline

  • Director

    Current role